Queen Mary Innovation Ltd (QMI) is Queen Mary University of London's (QMUL) wholly-owned technology transfer company and responsible for the commercialisation and management of the University’s intellectual property and portfolio of spinout companies. QMI protects and exploits QMUL's research-derived intellectual property and helps to maximise the economic and societal impact of that research.
QMUL study reveals biomarkers for pancreatic cancer
11 August 2015
QMI has a number of licensing opportunities currently available across the fields of BioPharma and Technology and Engineering.